Single continuous pressure; entirely spontaneous breathing.
Set
CPAP · FiO₂
Use
Cardiogenic pulmonary oedema, OSA, mild hypoxaemic failure.
Pros
Simple; recruits lungs; reduces preload in CPE.
Watch
No inspiratory support — not for fatigued patients.
Interpretation
—
Enter pH, PaCO₂ and HCO₃⁻ to interpret.
MAP
—
Enter both systolic and diastolic values.
P/F ratio
—
Enter PaO₂ and FiO₂.
GCS Total
15 / 15
Mild injury · E4 V5 M6
Assessment
0 Alert and calm
Spontaneously pays attention to caregiver.
Result
CAM-ICU negative
Delirium not present at this time.
CPOT total
0 / 8
No to mild pain
Total effluent
—
Enter weight + dose.
Citrate (4% solution)
—
Titrate to post-filter ionized Ca.
Replacement fluid
—
Pre- or post-filter
Dialysate
—
Counter-current to blood flow
Bolus dose
—
IV push over 1 min
Drip rate
—
Pump setting
—
Oral MME
—
Standardised reference.
Equianalgesic dose
—
As Morphine — PO
Recommended start
—
After 30% reduction
QTc
—
Enter QT and HR to calculate.
Hourly rate
—
4-2-1 rule
24-hour total
—
100-50-20 rule
Raw dose
—
Pre-cap
Administer
—
Within weight-based dose
Volume
—
From concentration
Result
—
Analyte
Reference range
Clinical note
Sodium (Na+)
135-145 mEq/L
Hyponatremia/Hypernatremia
Potassium (K+)
3.5-5.0 mEq/L
Cardiac arrhythmias risk
Chloride (Cl-)
98-106 mEq/L
—
Bicarbonate (HCO3-)
22-28 mEq/L
Acid-base status
Calcium (Ca2+)
8.5-10.5 mg/dL
Tetany/arrhythmia
Magnesium (Mg2+)
1.5-2.5 mEq/L
Neuromuscular, torsades
Creatinine
0.6-1.3 mg/dL
Renal function
BUN
7-20 mg/dL
Renal perfusion
Glucose (fasting)
70-99 mg/dL
DM screening
Hemoglobin
M 13.5-17.5 / F 12-16 g/dL
Anemia
Platelets
150-400 x10^3/µL
Bleeding risk
WBC
4-11 x10^3/µL
Infection/inflammation
pH (arterial)
7.35-7.45
Acid-base balance
PaCO2
35-45 mmHg
Respiratory component
HCO3- (ABG)
22-26 mEq/L
Metabolic component
PaO2
80-100 mmHg (room air)
Oxygenation
SaO2
≥95%
Oxygen saturation
Lactate
0.5-2.0 mmol/L
Tissue hypoperfusion
Base Excess
−2 to +2 mEq/L
Metabolic status
These tools are study and practice aids. They are not a substitute for clinical judgement, organisational policy or pharmacist verification of high-risk medications.